Enliven Therapeutics所有资讯

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

12/02 17:21 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(2.2%),Peter Kolchinsky(2.2%)等

11/14 17:53 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(8.5%),VHCP Co-Investment Holdings III, LLC(8.5%)等

11/14 17:51 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Citadel Advisors LLC(3.7%),Citadel Advisors Holdings LP(3.7%)等

11/14 16:29 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Fairmount Funds Management LLC(6.8%),Peter Harwin(6.8%)等

11/14 16:23 (美东)

Enliven Therapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-Commodore Capital LP(8.7%),Commodore Capital Master LP(8.7%)

11/14 16:15 (美东)

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-Polar Capital Holdings Plc(5.69%),Polar Capital LLP(5.69%)

11/13 17:57 (美东)

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(6.2%)

11/08 14:26 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

10/30 18:07 (美东)

Enliven Therapeutics | SC 13G：超过5%持股股东披露文件-BlackRock, Inc.(6.2%)

10/24 14:05 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Patel Anish

10/22 16:28 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Hohl Benjamin

10/22 16:24 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Kintz Samuel

10/22 16:24 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Lyssikatos Joseph P

10/22 16:24 (美东)

Enliven Therapeutics | 4：持股变动声明-董事 Heyman Richard A.

10/22 16:23 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Collins Helen Louise

10/22 16:19 (美东)

Enliven Therapeutics | 4：持股变动声明-董事 Heyman Richard A.

10/17 17:11 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Lyssikatos Joseph P

10/10 20:40 (美东)

Enliven Therapeutics | 4：持股变动声明-高管 Kintz Samuel

10/10 20:40 (美东)

Enliven Therapeutics | 4：持股变动声明-董事 Ballal Rahul D.

10/10 20:40 (美东)